Recombinant Mouse NKG2D Fc Chimera, CF

• Supplier: R&D Systems
• Catalog: 139-NK-050
• Category: Protein
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived
• Purity: >85%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: Q4FJM0
• Gene: KLRK1

Product References

Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound - Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound

Yoshida S, Mohamed RH, Kajikawa M, Koizumi J, Tanaka M, Fugo K, Otsuka N, Maenaka K, Yagita H, Chiba H, Kasahara M. J Immunol. 2012 Apr 15;188(8):3972-9.

Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural - Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural

Dibra D, Cutrera JJ, Xia X, Birkenbach MP, Li S. Cancer Res. 2009 Jul 1;69(13):5505-13.

Essential function for SAP family adaptors in the surveillance of hematopoietic - Essential function for SAP family adaptors in the surveillance of hematopoietic

Dong Z, Cruz-Munoz ME, Zhong MC, Chen R, Latour S, Veillette A. Nat Immunol. 2009 Sep;10(9):973-80.

Two novel NKG2D ligands of the mouse H60 family with differential expression - Two novel NKG2D ligands of the mouse H60 family with differential expression

Takada A, Yoshida S, Kajikawa M, Miyatake Y, Tomaru U, Sakai M, Chiba H, Maenaka K, Kohda D, Fugo K, Kasahara M. J Immunol. 2008 Feb 1;180(3):1678-85.

Intrinsic sensor of oncogenic transformation induces a signal for innate - Intrinsic sensor of oncogenic transformation induces a signal for innate

Unni AM, Bondar T, Medzhitov R. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1686-91. doi:

Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by - Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by

Kotturi HS, Li J, Branham-O'Connor M, Stickel SL, Yu X, Wagner TE, Wei Y. Gene Ther. 2008 Oct;15(19):1302-10.

Generation, affinity maturation, and characterization of a human anti-human NKG2D - Generation, affinity maturation, and characterization of a human anti-human NKG2D

Kwong KY, Baskar S, Zhang H, Mackall CL, Rader C. J Mol Biol. 2008 Dec 31;384(5):1143-56.

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer. - Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.

Barber A, Zhang T, DeMars LR, Conejo-Garcia J, Roby KF, Sentman CL. Cancer Res. 2007 May 15;67(10):5003-8.

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging - DNA-based vaccines activate innate and adaptive antitumor immunity by engaging

Zhou H, Luo Y, Lo JF, Kaplan CD, Mizutani M, Mizutani N, Lee JD, Primus FJ, Becker JC, Xiang R, Reisfeld RA. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10846-51. Epub 2005 Jul 22.